JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
Nat Rev Drug Discov
.
2017 Dec 28;17(1):78.
doi: 10.1038/nrd.2017.267.
Authors
Daniella M Schwartz
,
Yuka Kanno
,
Alejandro Villarino
,
Michael Ward
,
Massimo Gadina
,
John J O'Shea
PMID:
29282366
PMCID:
PMC6168198
DOI:
10.1038/nrd.2017.267
Abstract
This corrects the article DOI: 10.1038/nrd.2017.201.
Publication types
Published Erratum
Grants and funding
Z99 AI999999/Intramural NIH HHS/United States